rel-(1R,1'r,4R,4'R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane)

Catalog No. :
ACILHM065
CAS No. :
139215-80-8
Molecular Formula :
C20H27F3
Molecular Weight :
324.43

IUPAC Name:(1r,1'r,4R,4'R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane)

rel-(1R,1'r,4R,4'R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$87.00Login to see priceIn stockInquiry
500g98%$341.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,1'r,4R,4'R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane)
IUPAC Name(1r,1'r,4R,4'R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane)
MDL No.MFCD12911825
Molecular FormulaC20H27F3
Molecular Weight324.43
SMILESFC1=C(F)C(F)=CC([C@H]2CC[C@H]([C@H]3CC[C@H](CC)CC3)CC2)=C1
InChI KeyDXFHMMVZUZLQFU-BIAGXBKMSA-N
SynonymJ-500352 | trans(trans)-4-Ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane) | 4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexyl) | SCHEMBL14274421 | CS-0153909 | rel-(1R,1'r,4R,4'R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane) | trans,t
CAS No.139215-80-8
PubChem CID14984828

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H413
Precautionary Statement(s)
P264-P273-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACILHM065 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACILHM065 route product structure diagram
    ACILHM065139215-80-8 In Stock
Inquiry

2. ACILHM065 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACILHM065 route product structure diagram
    ACILHM065139215-80-8 In Stock
Inquiry

Comments (0)